Valneva (NASDAQ:VALN – Free Report) had its target price trimmed by HC Wainwright from $18.00 to $17.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage ...
Valneva has bolstered its vaccines pipeline ... known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback